MAHA is mad. Its alliance with Trump is about to face its biggest test

• The Supreme Court will hear arguments on whether federal law preempts state lawsuits over Roundup's alleged cancer risks, with the Trump administration filing an amicus brief supporting Bayer and arguing against a 'patchwork of 50 different labeling requirements.'
• The House farm bill includes provisions MAHA advocates call a 'liability shield' that would prohibit states from requiring pesticide labeling beyond EPA-approved standards, sparking backlash from the movement that helped deliver Trump to the White House.
• MAHA advocates warn they may sit out the 2026 midterms rather than vote for Republicans if the administration continues supporting glyphosate, creating an opportunity for Democrats to court these previously non-political voters on health issues.

Market Summary: MAHA Movement Challenges Republican Alliance Over Glyphosate

Key Developments

The Make America Healthy Again (MAHA) movement faces a critical clash with the Trump administration and Republican lawmakers this week over glyphosate, the active ingredient in Bayer's Roundup weedkiller. Two major events are testing the political alliance: a Supreme Court case beginning Monday and House consideration of the farm bill.

Legal and Legislative Action

The Supreme Court will determine whether federal law preempts state-level lawsuits claiming glyphosate causes cancer. The Trump administration is arguing on behalf of Bayer, asserting that the Federal Insecticide, Fungicide and Rodenticide Act should override "failure to warn" claims to prevent manufacturers from facing varying labeling requirements across 50 states.

Simultaneously, the House farm bill includes provisions MAHA advocates characterize as a "liability shield" for pesticide manufacturers, prohibiting states from requiring labeling beyond EPA-approved standards.

Political Implications

This confrontation follows February tensions when Trump signed an executive order boosting domestic glyphosate production, prompting intervention from HHS Secretary Robert F. Kennedy Jr. With Trump's approval ratings declining and the 2026 midterm elections seven months away, maintaining Republican congressional majorities may depend on preserving the MAHA coalition.

MAHA advocate Kelly Ryerson warned frustrated supporters may simply abstain from voting rather than switch parties. Democrats, led by Rep. Chellie Pingree (D-Maine), see an opportunity to court MAHA voters on health issues.

Corporate Impact

Bayer faces continued legal pressure, having previously paid nearly $290 million in one cancer-related case. The Supreme Court decision and farm bill outcome will significantly affect the company's liability exposure and operational costs related to product labeling compliance.